Showing results (121-130 of 145) with videos related to
Sort By:
Pageof 15
International Journal of Medical Informatics|September 11, 2010
Computerized physician order entry of injectable antineoplastic drugs: an epidemiologic study of prescribing medication errorsV Nerich, S Limat, M Demarchi, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Effect of cell determinant (CD)34+ cell dose on the cost and consequences of peripheral blood stem cell transplantation for non-Hodgkin's lymphoma patients in front-line therapyS Limat, M C Woronoff-Lemsi, N Milpied, et al.Clinical Drug Investigation|May 30, 2007
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's LymphomaSamuel Limat, Karine Demesmay, Philippe Fagnoni, et al.Cancer Immunology, Immunotherapy : CII|July 18, 2020
Economic evaluations of cancer immunotherapy: a systematic review and quality evaluationCharlotte Couchoud, Philippe Fagnoni, François Aubin, et al.Clinical Genitourinary Cancer|October 26, 2017
Factors Influencing Overall Survival for Patients With Metastatic Clear-Cell Renal-Cell Carcinoma in Daily PracticeAntoine Thiery-Vuillemin, Tiphaine Cholley, Fabien Calcagno, et al.Clinical Drug Investigation|September 26, 2016
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal TumorsVirginie Nerich, Camille Fleck, Loïc Chaigneau, et al.Plos One|September 7, 2012
Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatmentGilles Capellier, Hélène Mockly, Claire Charpentier, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 26, 2013
First-line trastuzumab plus taxane-based chemotherapy for metastatic breast cancer: cost-minimization analysisVirginie Nerich, Jennifer Chelly, Philippe Montcuquet, et al.Breast (Edinburgh, Scotland)|December 26, 2013
Long-term follow-up of patients with metastatic breast cancer treated by trastuzumab: impact of institutionsFrederic Fiteni, Cristian Villanueva, Fernando Bazan, et al.Bulletin Du Cancer|October 17, 2019
[Adjuvant hormonal therapy for early breast cancer: Assessment of patients' satisfaction]Julie Vardanega, Julie Henriques, Charlotte Pourcelot, et al.Pageof 15